Glucon is a development stage company developing glucose monitoring devices for the diabetes market.
Glucon is a development stage company developing glucose monitoring devices for the diabetes market. The Glucon devices will provide continuous, accurate, and real-time glucose monitoring, for clinical and personal use. Glucon devices are based on a novel Photoacoustic (optical and sound-based) technology protected by several granted and pending patents, and intended to be incorporated into a small, conveniently wearable instrument (the Personal Device).The company has shown that Photoacoustics, a unique combinatorial technology, is superior to optics alone, as it attains blood glucose measurements directly from inside the blood vessels and is an improved method both for specificity (identification) and sensitivity (detection of level changes) of the glucose measurement.The company’s desktop prototype device is currently undergoing extensive clinical trials.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 7, 2004 | Series A | $13M | 1 | Innomed Ventures | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Innomed Ventures | Yes | Series A |